We were promised a vaccine that would protect us from infection, and if infected, it would ensure we would not have severe symptoms, and the chance of death was significantly reduced. Unfortunately, however, that is not reality.
Our real-world today is one of the temporary vaccines with monthly booster shots. And, on top of that, more and more fully vaccinated people are ending up in hospitals and dying – many more than we expected or were promised.
https://republicanpost.net/scientists-in-texas-announce-affordable-covid-vaccine/. Corbevax has been developed in Texas and is the latest vaccine, hopefully not a temporary vaccine like the ones available today. This vaccine was started almost twenty years ago – long before our current pandemic. However, the early work led to a usable and effective vaccine against the SARS-CoV-2 virus.
Testing to date has been done in India. It is effective, safe, and affordable. The developers expect that it will be a game-changer for poorer countries. NPR (National Public Radio) reported that the vaccine is effective in preventing infection from COVID-19
https://www.theblaze.com/news/texas-scientists-say-they-have-developed-a-game-changer-affordable-covid-vaccine-ignored-by-us-government. The India clinical trials showed that the vaccine is 90% effective against the original viral strain and 80% effective against the Delta variant. Testing is ongoing with the Omicron variant.
https://www.npr.org/sections/goatsandsoda/2022/01/05/1070046189/a-texas-team-comes-up-with-a-covid-vaccine-that-could-be-a-global-game-changer. The research began at George Washington University around 20 years ago. The original focus was on tropical infectious diseases. Emphasis shifted when SARS broke out in 2003. Work was continued at the Baylor University College of Medicine and the Texas Children’s Center for Vaccine Development in Houston, Texas.
The SARS outbreak fizzled out before the vaccine could be fully developed. So when coronavirus entered our world two years ago, scientists resurrected the earlier SARS work and applied it to COVID-19.
https://www.historyofvaccines.org/content/articles/different-types-vaccines. Some vaccines use live (attenuated) viruses such as measles, mumps, and chickenpox. Other vaccines may use inactivated (dead) viruses such as Hepatitis A or polio. Inactivated toxin vaccines are effective against diphtheria and tetanus. This past year, we were made aware of the mRNA vaccine with the currently authorized COVID-19 vaccines manufactured by Pfizer and Moderna.
The Corbevax vaccine uses a process that has been effective for Hepatitis B, Pertussis, Pneumonia, Meningitis, and sepsis. They are called protein subunit vaccines. These types of vaccines cause the immune system to respond effectively when the protein subunit associated with a specific virus enters the body. This technology has been around a long time and has had longstanding effective results.
When the mRNA vaccines were introduced, I was skeptical and made my opinion well known in many of the articles I wrote that I would wait several months before deciding about getting that type of vaccine. However, I felt that a viral vector would probably be my choice because it was older technology. Viral vector vaccines have been around for decades. Examples are those used against Ebola, Zika, HIV, and influenza.
I planned to make my announcement and get a vaccine in September 2021. But, alas, that did not happen. Instead, I was blessed with a mild case of the Delta variant and only had a cough and fatigue for a few days.
I never got a vaccine, and recent studies now solidify my thoughts that naturally acquired immunity is the best type. Temporary vaccine immunity wanes with time. Will Corbavax wane with time? We shall see in six months to a year.
The new Texas COVID-19 vaccine is much less expensive than the current COVID-19 vaccines and can be produced, stored, and administered more efficiently than existing coronavirus vaccines.
The researchers developing Corbevax said their protein subunit vaccine was available for public use at the lowest possible price. The Texas research team received funding from private charities and philanthropies in New York and Texas.
Live Longer & Enjoy Life! – Red O’Laughlin – RedOLaughlin.com